Ceritinib
Category: CancerCeritinib Overview
Ceritinib (INN,[2] trade name Zykadia /zakedi/ zy-KAY-dee-) is a prescription-only drug used for the treatment of non-small cell lung cancer (NSCLC).[3] It was developed by Novartis and received FDA approval for use in April 2014.[3] Contents 1 Medical uses 2 Pharmacology 2.1 Mechanism of action 2.2 Adverse effects 2.3 Dose 3 Research and development 4 Commercialization 4.1 Cost 5 Intellectual property 6 See also 7 References 8 External ...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ceritinib
Recent Ceritinib Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Ceritinib
- Capsule: 150mg
- Tablet: 150mg
Other drugs which contain Ceritinib or a similar ingredient: (1 result)
- ZYKADIA Ceritinib